The rise of Viagra initially sparked a surge for pharma, nevertheless recent shifts present a uncertain scenario for shareholders. Lower-cost competitors are eroding profits, and persistent legal battles add further https://nanajunl630270.ttblogs.com/21110223/sildenafil-and-pharma-a-risky-play